Cargando…
Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis
A quantitative method is presented to rank strengths, weaknesses, opportunities, and threats (SWOT) of modified vaccinia virus Ankara (MVA) as a platform for pre-pandemic and pandemic influenza vaccines. Analytic hierarchy process (AHP) was applied to achieve pairwise comparisons among SWOT factors...
Autores principales: | Ramezanpour, Bahar, Pronker, Esther S., Kreijtz, Joost H.C.M., Osterhaus, Albert D.M.E., Claassen, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550479/ https://www.ncbi.nlm.nih.gov/pubmed/26048779 http://dx.doi.org/10.1016/j.vaccine.2015.04.086 |
Ejemplares similares
-
Food-Pharma Convergence in Medical Nutrition– Best of Both Worlds?
por: Weenen, Tamar C., et al.
Publicado: (2013) -
Vector-based genetically modified vaccines: Exploiting Jenner’s legacy
por: Ramezanpour, Bahar, et al.
Publicado: (2016) -
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
por: Altenburg, Arwen F., et al.
Publicado: (2014) -
Key opinion leaders — a critical perspective
por: Scher, Jose U., et al.
Publicado: (2020) -
Social Media - Key Opinion Leaders of the Future?
por: Rothfischer, Kathrin
Publicado: (2021)